Oral Live Vaccine Strain-Induced Protective Immunity against Pulmonary Francisella tularensis Challenge Is Mediated by CD4+ T Cells and Antibodies, Including Immunoglobulin A

ABSTRACT Francisella tularensis is an intracellular gram-negative bacterium and the etiological agent of pulmonary tularemia. Given the high degrees of infectivity in the host and of dissemination of bacteria following respiratory infection, immunization strategies that target mucosal surfaces are critical for the development of effective vaccines against this organism. In this study, we have characterized the efficacy of protective immunity against pneumonic tularemia following oral vaccination with F. tularensis LVS (live vaccine strain). Mice vaccinated orally with LVS displayed colocalization of LVS with intestinal M cells, with subsequent enhanced production of splenic antigen-specific gamma interferon and of systemic and mucosal antibodies, including immunoglobulin A (IgA). LVS-vaccinated BALB/c mice were highly protected against intranasal (i.n.) SCHU S4 challenge and exhibited significantly less bacterial replication in the lungs, liver, and spleen than mock-immunized animals. Depletion of CD4+ T cells significantly abrogated the protective immunity, and mice deficient in B cells or IgA displayed partial protection against SCHU S4 challenge. These results suggest that oral vaccination with LVS induces protective immunity against i.n. challenge with F. tularensis SCHU S4 by a process mediated cooperatively by CD4+ T cells and antibodies, including IgA.

[1]  B. Arulanandam,et al.  CD4+ T cells are required during priming but not the effector phase of antibody‐mediated IFN‐γ‐dependent protective immunity against pulmonary Francisella novicida infection , 2008, Immunology and cell biology.

[2]  B. Arulanandam,et al.  Mast cells inhibit intramacrophage Francisella tularensis replication via contact and secreted products including IL-4 , 2008, Proceedings of the National Academy of Sciences.

[3]  S. Chakraborty,et al.  Characterization of the Francisella tularensis subsp. novicida type IV pilus. , 2008, Microbiology.

[4]  Y. Li,et al.  Utilization of Fc Receptors as a Mucosal Vaccine Strategy against an Intracellular Bacterium, Francisella tularensis1 , 2008, The Journal of Immunology.

[5]  B. Arulanandam,et al.  The presence of infectious extracellular Francisella tularensis subsp. novicida in murine plasma after pulmonary challenge , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[6]  S. Fukuyama,et al.  A novel M cell–specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses , 2007, The Journal of experimental medicine.

[7]  O. Lyubomska,et al.  Oral vaccination: where we are? , 2007, Expert opinion on drug delivery.

[8]  J. Benach,et al.  Francisella tularensis has a significant extracellular phase in infected mice. , 2007, The Journal of infectious diseases.

[9]  Wangxue Chen,et al.  Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis. , 2007, Vaccine.

[10]  J. Belisle,et al.  Active Suppression of the Pulmonary Immune Response by Francisella tularensis Schu41 , 2007, The Journal of Immunology.

[11]  Wangxue Chen,et al.  Intestinal M cells: the fallible sentinels? , 2007, World journal of gastroenterology.

[12]  D. Metzger,et al.  Inactivated Francisella tularensis Live Vaccine Strain Protects against Respiratory Tularemia by Intranasal Vaccination in an Immunoglobulin A-Dependent Fashion , 2007, Infection and Immunity.

[13]  D. Kasper,et al.  A Defined O-Antigen Polysaccharide Mutant of Francisella tularensis Live Vaccine Strain Has Attenuated Virulence while Retaining Its Protective Capacity , 2007, Infection and Immunity.

[14]  B. J. Hinnebusch,et al.  Oral Vaccination with Salmonella Simultaneously Expressing Yersinia pestis F1 and V Antigens Protects against Bubonic and Pneumonic Plague1 , 2007, The Journal of Immunology.

[15]  B. Arulanandam,et al.  The protective efficacy of chlamydial protease-like activity factor vaccination is dependent upon CD4+ T cells. , 2006, Cellular immunology.

[16]  B. Arulanandam,et al.  Intranasal Vaccination with a Defined Attenuated Francisella novicida Strain Induces Gamma Interferon-Dependent Antibody-Mediated Protection against Tularemia , 2006, Infection and Immunity.

[17]  A. Sjöstedt,et al.  Virulence comparison in mice of distinct isolates of type A Francisella tularensis. , 2006, Microbial pathogenesis.

[18]  Terry H Wu,et al.  Intranasal Vaccination Induces Protective Immunity against Intranasal Infection with Virulent Francisella tularensis Biovar A , 2005, Infection and Immunity.

[19]  P. Oyston,et al.  Tularemia vaccine: past, present and future , 2005, Antonie van Leeuwenhoek.

[20]  D. Metzger,et al.  Intranasal Interleukin-12 Treatment for Protection against Respiratory Infection with the Francisella tularensis Live Vaccine Strain , 2005, Infection and Immunity.

[21]  Wangxue Chen,et al.  Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism. , 2005, Vaccine.

[22]  D. Frank,et al.  Construction and Characterization of a Highly Efficient Francisella Shuttle Plasmid , 2004, Applied and Environmental Microbiology.

[23]  B. Arulanandam,et al.  Intranasal Interleukin-12 Treatment Promotes Antimicrobial Clearance and Survival in Pulmonary Francisella tularensis subsp. novicida Infection , 2004, Antimicrobial Agents and Chemotherapy.

[24]  Wangxue Chen,et al.  Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis. , 2004, Microbial pathogenesis.

[25]  S. Fukuyama,et al.  NALT- versus PEYER'S-patch-mediated mucosal immunity , 2004, Nature Reviews Immunology.

[26]  B. Arulanandam,et al.  Chlamydia trachomatis pulmonary infection induces greater inflammatory pathology in immunoglobulin A deficient mice. , 2004, Cellular immunology.

[27]  Wangxue Chen,et al.  Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen. , 2004, Vaccine.

[28]  C. Sasakawa,et al.  Intestinal villous M cells: an antigen entry site in the mucosal epithelium. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Wangxue Chen,et al.  Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background. , 2003, Vaccine.

[30]  I. Smoak,et al.  Influence of Pregnancy on the Pathogenesis of Listeriosis in Mice Inoculated Intragastrically , 2003, Infection and Immunity.

[31]  A. Tärnvik,et al.  Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica. , 2003, Microbial pathogenesis.

[32]  R. Titball,et al.  Will the enigma of Francisella tularensis virulence soon be solved? , 2003, Trends in microbiology.

[33]  N. Mantis,et al.  Selective Adherence of IgA to Murine Peyer’s Patch M Cells: Evidence for a Novel IgA Receptor1 , 2002, The Journal of Immunology.

[34]  B. Arulanandam,et al.  Intranasal Vaccination with Pneumococcal Surface Protein A and Interleukin-12 Augments Antibody-Mediated Opsonization and Protective Immunity against Streptococcus pneumoniae Infection , 2001, Infection and Immunity.

[35]  C. Pilette,et al.  Lung mucosal immunity: immunoglobulin-A revisited. , 2001, The European respiratory journal.

[36]  R. Monteiro,et al.  Colostral neutrophils express Fcα receptors (CD89) lacking γ chain association and mediate noninflammatory properties of secretory IgA , 2001, Journal of Leukocyte Biology.

[37]  B. Arulanandam,et al.  IgA Immunodeficiency Leads to Inadequate Th Cell Priming and Increased Susceptibility to Influenza Virus Infection , 2001, The Journal of Immunology.

[38]  P. Sansonetti,et al.  M cells as ports of entry for enteroinvasive pathogens: mechanisms of interaction, consequences for the disease process. , 1999, Seminars in immunology.

[39]  E. S. Baekkevold,et al.  Regional specialization in the mucosal immune system: what happens in the microcompartments? , 1999, Immunology today.

[40]  K. Elkins,et al.  Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS. , 1996, Journal of immunology.

[41]  K. Elkins,et al.  Minimal requirements for murine resistance to infection with Francisella tularensis LVS , 1996, Infection and immunity.

[42]  A. Sjöstedt,et al.  The requirement of tumour necrosis factor-α and interferon-γ for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculum , 1996 .

[43]  M. Eibl,et al.  Human serum IgA downregulates the release of inflammatory cytokines (tumor necrosis factor-alpha, interleukin-6) in human monocytes. , 1994, Blood.

[44]  A. Bradley,et al.  Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. , 1993, Science.

[45]  R. Zinkernagel,et al.  Immune response in mice that lack the interferon-gamma receptor. , 1993, Science.

[46]  J. Pappo,et al.  Follicle epithelial M cells are a source of interleukin-1 in Peyer's patches. , 1993, Immunology.

[47]  A. Fortier,et al.  T-cell-independent resistance to infection and generation of immunity to Francisella tularensis , 1993, Infection and immunity.

[48]  A. Fortier,et al.  Introduction of Francisella tularensis at skin sites induces resistance to infection and generation of protective immunity. , 1992, Microbial pathogenesis.

[49]  R. Schreiber,et al.  In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies , 1992, Infection and immunity.

[50]  Klaus Rajewsky,et al.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene , 1991, Nature.

[51]  E. Ghadirian,et al.  The requirement for gamma interferon in resistance of mice to experimental tularemia. , 1989, Microbial pathogenesis.

[52]  A. Tärnvik.  Nature of protective immunity to Francisella tularensis. , 1989, Reviews of infectious diseases.

[53]  G. Volkheimer.  Passage of particles through the wall of the gastrointestinal tract , 1974, Environmental health perspectives.

[54]  R. Hornick,et al.  Aerogenic immunization of man with live Tularemia vaccine. , 1966, Bacteriological reviews.

[55]  H. T. Eigelsbach,et al.  Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. , 1961, Journal of immunology.

[56]  H. Wilson,et al.  Tularemia vaccine study. II. Respiratory challenge. , 1961, Archives of internal medicine.

[57]  H. Wilson,et al.  Tularemia vaccine study. I. Intracutaneous challenge. , 1961, Archives of internal medicine.

[58]  C. Hill,et al.  M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis. , 2008, FEMS immunology and medical microbiology.

[59]  Wangxue Chen,et al.  M cell-targeted delivery of vaccines and therapeutics. , 2008, Expert opinion on drug delivery.

[60]  D. Metzger,et al.  Prophylactic and Therapeutic Use of Antibodies for Protection against Respiratory Infection with Francisella tularensis , 2007 .

[61]  A. Zuercher.  Upper respiratory tract immunity. , 2003, Viral immunology.

[62]  R. Monteiro,et al.  Colostral neutrophils express Fc alpha receptors (CD89) lacking gamma chain association and mediate noninflammatory properties of secretory IgA. , 2001, Journal of leukocyte biology.

[63]  M. Lamm.  Interaction of antigens and antibodies at mucosal surfaces. , 1997, Annual review of microbiology.

[64]  A. Sjöstedt,et al.  The requirement of tumour necrosis factor-alpha and interferon-gamma for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculum. , 1996, Microbiology.

[65]  R. Walker,et al.  New strategies for using mucosal vaccination to achieve more effective immunization. , 1994, Vaccine.

[66]  J. Bienenstock,et al.  Mucosal immunity. , 1980, Monographs in allergy.

[67]  D. Burke.  Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. , 1977, The Journal of infectious diseases.